About
Oxalo Therapeutics is developing first-in-class peptide therapeutics inspired by the gut microbe Oxalobacter formigenes to treat rare kidney diseases such as primary hyperoxaluria and prevent recurrent kidney stones.
Explore Oxalo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.